Skip to main content

Advertisement

SpringerLink
Log in

Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer

  • ORIGINAL ARTICLE
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Recurrent ovarian cancer is refractory and resistant to treatment in most patients, and no effective treatment for it has been established. Starting a treatment when tumors still consist of micro foci may contribute to improvement of prognosis. Therefore, the early diagnosis of relapse is important.

Methods

Among patients with epithelial ovarian cancer in whom initial treatment achieved remission between April 1998 and December 2003, those patients in whom the cancer-related antigen (CA)125 level was increased during the subsequent follow-up period, or those who showed abnormal computed tomography (CT)/magnetic resonance imaging (MRI) findings despite normal CA125 levels, were examined by 18F-fluoro-2-deoxyglucose – positron emission tomography (FDG-PET). We compared the rates of accurate diagnosis of recurrence achieved using CT/MRI, CA125, and FDG-PET in patients with a definitive diagnosis of relapse.

Results

We investigated 29 patients with epithelial ovarian cancer. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of FDG-PET were 84.6% (22/26), 100% (3/3), 100% (22/22), 42.9% (3/7), and 86.2% (25/29), respectively. These values were higher than the corresponding values obtained using CT/MRI or CA125 levels.

Conclusion

FDG-PET may be very useful for identifying sites of recurrent ovarian cancer, although this procedure had a low NPV because of the high rate of false-negative findings for micro or cystic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. GJS Rustin AE Nelstrop MK Tuxen et al. (1996) ArticleTitleDefining progression of ovarian carcinoma during follow-up according to CA125: a North Thames Ovary Group study Ann Oncol 7 361–364 Occurrence Handle1:STN:280:BymA1MbktlA%3D Occurrence Handle8805927

    CAS  PubMed  Google Scholar 

  2. GJS Rustin MEL van der Burg JS Berek (1993) ArticleTitleTumor markers Ann Oncol 4 IssueIDs4 S71–S77

    Google Scholar 

  3. B Patsner JW Orr SuffixJr WJ Mann et al. (1990) ArticleTitleDoes serum CA125 level prior to second look laparotomy for invasive ovarian adenocarcinoma predict size of residual disease Gynecol Oncol 38 373–376 Occurrence Handle10.1016/0090-8258(90)90076-W Occurrence Handle1:STN:280:By6D3szitVc%3D Occurrence Handle2227551

    Article  CAS  PubMed  Google Scholar 

  4. SC Rubin WJ Hoskins TB Hakes et al. (1989) ArticleTitleSerum CA125 Levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer Am J Obstet Gynecol 160 667–671 Occurrence Handle1:STN:280:BiaC1M%2FovVc%3D Occurrence Handle2648838

    CAS  PubMed  Google Scholar 

  5. M Zimny W Siggelkow W Schroder et al. (2001) ArticleTitle2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer Gynecol Oncol 83 310–315 Occurrence Handle10.1006/gyno.2001.6386 Occurrence Handle1:STN:280:DC%2BD3MrmtVKgtA%3D%3D Occurrence Handle11606090

    Article  CAS  PubMed  Google Scholar 

  6. GJS Rustin A Nelstrop J Stilwell et al. (1992) ArticleTitleSaving obtained by CA125 measurements during therapy for ovarian carcinoma Eur J Cancer 28 79–82 Occurrence Handle10.1016/0959-8049(92)90390-N Occurrence Handle1:STN:280:By2B3s3ktlc%3D Occurrence Handle1567697

    Article  CAS  PubMed  Google Scholar 

  7. LG Strauss PS Conti (1991) ArticleTitleThe application of PET in clinical oncology J Nucl Med 32 623–648 Occurrence Handle1:STN:280:By6C1MzotVY%3D Occurrence Handle2013803

    CAS  PubMed  Google Scholar 

  8. R Bar Shalom AY Valdivia MD Blaufox et al. (2000) ArticleTitlePET imaging in oncology Semin Nucl Med 3 150–185

    Google Scholar 

  9. R Tucker M Coel J Ko et al. (2001) ArticleTitleImpact of fluorine-18 fluorodeoxyglucose positron emission tomography on patient management: first year’s experience in a clinical center J Clin Oncol 19 2504–2508 Occurrence Handle1:STN:280:DC%2BD3MzgvFGksA%3D%3D Occurrence Handle11331329

    CAS  PubMed  Google Scholar 

  10. PG Rose (2000) ArticleTitleSurgery for recurrent ovarian cancer Semin Oncol 3 IssueIDs7 17–23

    Google Scholar 

  11. SK Chambers JT Chambers EI Kohorn et al. (1988) ArticleTitleEvaluation of the role of second look surgery in ovarian cancer Obstet Gynecol 72 404–408 Occurrence Handle1:STN:280:BieA3c3ovFc%3D Occurrence Handle3405557

    CAS  PubMed  Google Scholar 

  12. ME Potter KD Hatch SJ Soong et al. (1991) ArticleTitleSecond look laparotomy and salvage therapy: a research modality only? Gynecol Oncol 44 3–9 Occurrence Handle10.1016/0090-8258(92)90002-Z

    Article  Google Scholar 

  13. RC Young (1987) ArticleTitleA second look at second look laparotomy J Clin Oncol 5 1311–1313 Occurrence Handle1:STN:280:BiiA3M%2FlvVQ%3D Occurrence Handle3625251

    CAS  PubMed  Google Scholar 

  14. JB Friedman NS Weiss (1991) ArticleTitleSecond thoughts about second look laparotomy in advanced ovarian cancer N Engl J Med 322 1079–1080

    Google Scholar 

  15. JS Berek (1992) ArticleTitleSecond-Look versus second-nature Gynecol Oncol 44 1–2 Occurrence Handle10.1016/0090-8258(92)90001-Y Occurrence Handle1:STN:280:By2C3M3htVQ%3D Occurrence Handle1730414

    Article  CAS  PubMed  Google Scholar 

  16. H Meden W Rath D Ohlmeyer (1990) ArticleTitleThe value of preoperative diagnosis before second-look laparotomy in ovarian cancer Geburtshilfe Frauenheilkd 50 102–105

    Google Scholar 

  17. T Torizuka S Nobezawa T Kanno et al. (2002) ArticleTitleOvarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-d-glucose Eur J Nucl Med 29 797–803 Occurrence Handle10.1007/s00259-001-0750-9 Occurrence Handle1:CAS:528:DC%2BD38XlvVWmsrY%3D

    Article  CAS  Google Scholar 

  18. RF Yen S-S Sun Y-Y Shen et al. (2001) ArticleTitleWhole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer Anticancer Res 21 3691–3694 Occurrence Handle1:STN:280:DC%2BD387hsFWqsQ%3D%3D Occurrence Handle11848544

    CAS  PubMed  Google Scholar 

  19. MEL van der Burg M van Lent (1995) ArticleTitleThe effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer N Engl J Med 332 629–934 Occurrence Handle10.1056/NEJM199503093321002 Occurrence Handle1:STN:280:ByqC2cjptlY%3D Occurrence Handle7845426

    Article  CAS  PubMed  Google Scholar 

  20. SM Eisenkop RL Friedman (2000) ArticleTitleThe role of second cytoreductive surgery in the treatment of patient with recurrent epithelial ovarian carcinoma Cancer 88 144–153 Occurrence Handle10.1002/(SICI)1097-0142(20000101)88:1<144::AID-CNCR20>3.0.CO;2-X Occurrence Handle1:STN:280:DC%2BD3c%2Fos1OmsA%3D%3D Occurrence Handle10618617

    Article  CAS  PubMed  Google Scholar 

  21. S Makhija P Sabbatini C Aghajanian et al. (1999) ArticleTitleIntraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian patients with a positive second look Gynecol Oncol 79 28–32 Occurrence Handle10.1006/gyno.2000.5890

    Article  Google Scholar 

  22. M Markman MF Brady NM Spirtos et al. (1998) ArticleTitlePhase II trial of intraperitoneal paclitaxel in carcinoma of the ovary, tube, and peritoneum: a gynecologic Oncology Group Study J Clin Oncol 16 2620–2624 Occurrence Handle1:CAS:528:DyaK1cXlsFCgur4%3D Occurrence Handle9704711

    CAS  PubMed  Google Scholar 

  23. BY Karlan R Hawkins C Hoh et al. (1993) ArticleTitleWhole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-d-glucose can detect recurrent ovarian carcinoma Gynecol Oncol 51 175–181 Occurrence Handle10.1006/gyno.1993.1268 Occurrence Handle1:STN:280:ByuC3c3lvFM%3D Occurrence Handle8276290

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecology, Hamamatsu Medical Center, 328 Tomitsukacho, Hamamatsu, 432-8580, Japan

    Munetaka Takekuma & Makoto Maeda

  2. Department of Pathology, Hamamatsu Medical Center, Hamamatsu, Japan

    Takachika Ozawa & Kazuhiko Yasumi

  3. Positron Medical Center, Hamamatsu Medical Center, Hamamatsu, Japan

    Tatsuo Torizuka

Authors
  1. Munetaka Takekuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Makoto Maeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takachika Ozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuhiko Yasumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tatsuo Torizuka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Munetaka Takekuma.

About this article

Cite this article

Takekuma, M., Maeda, M., Ozawa, T. et al. Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. Int J Clin Oncol 10, 177–181 (2005). https://doi.org/10.1007/s10147-005-0489-6

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-005-0489-6

Key words

Search

Navigation